Cancer Treatment Reviews
Volume 29, Supplement 1 , Pages 33-39, May 2003

Clinical update: proteasome inhibitors in hematologic malignancies

  • Paul Richardson

      Affiliations

    • Corresponding Author InformationCorrespondence to: Paul Richardson MD, Jerome Lipper Multiple Myeloma Center, Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Tel.: 1-617-632-2104; Fax: 1-617-632-6624

Dana-Farber Cancer Institute, Boston, MA 02115, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(03)00080-X

doi:10.1016/S0305-7372(03)00080-X

Cancer Treatment Reviews
Volume 29, Supplement 1 , Pages 33-39, May 2003

Article Tools

* Image Usage & Resolution